Cordis Webster
This article was originally published in The Gray Sheet
Executive Summary
Additional indications for the Celsius 6 and 7 Fr. temperature ablation catheters are approved Jan. 26 via premarket approval application supplement. The Johnson & Johnson unit's deflectable tip catheters are the first to gain U.S. clearance for the pediatric market and can be used on patients age four and older. Other indications include the interruption of accessory atrioventricular (AV) pathways associated with persistent junctional reciprocating tachycardia (PJRT), and treatment of Mahaim fibers, a congenital anomaly that creates accessory conduction pathways
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.